|
|||||
|
|
Reply to Perris,Borghese, and Magro |
|
| Authors: | Jonathan E. Zuckerman Antoni Ribas Mark E. Davis |
| Affiliation: | 1. Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA;2. Surgical Oncology/Department of Surgery;3. Hematology & Oncology/Department of Medicine;4. Jonsson Comprehensive Cancer Center;5. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California |
| Abstract: | |
| Keywords: | |